CONMED Corporation (CNMD) |
|
100.85 -0.64 (-0.63%)
|
09-29 16:00 |
|
Open: |
102.32 |
Pre. Close: |
101.49 |
|
High:
|
102.76 |
Low:
|
100.69 |
|
Volume:
|
176,391 |
Market Cap:
|
3,100(M) |
|
|
|
Technical analysis |
as of: 2023-09-29 4:26:40 PM |
|
Short-term rate:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 125.79 One year: 133.47 |
| Support: |
Support1: 97.06 Support2: 80.75 |
| Resistance: |
Resistance1: 107.7 Resistance2: 114.27 |
| Pivot: |
104.33  |
| Moving Average: |
MA(5): 100.3 MA(20): 105.33
MA(100): 119.27 MA(250): 104.12  |
| MACD: |
MACD(12,26): -3.2 Signal(9): -2.9 |
| Stochastic oscillator: |
%K(14,3): 21.8 %D(3): 14.1 |
| RSI: |
RSI(14): 37.1 |
| 52-week: |
High: 138.47 Low: 71.08 |
| Average Vol(K): |
3-Month: 347 (K) 10-Days: 285 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CNMD ] has closed above bottom band by 26.3%. Bollinger Bands are 9.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
102.89 - 103.39 |
103.39 - 103.88 |
|
Low:
|
99.21 - 99.84 |
99.84 - 100.46 |
|
Close:
|
99.69 - 100.68 |
100.68 - 101.66 |
|
Company Description |
|
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. |
Headline News |
Sun, 01 Oct 2023
Ronald Blue Trust Inc. Sells 3017 Shares of CONMED Co. (NYSE ... - MarketBeat
Sat, 30 Sep 2023
CONMED (NYSE:CNMD) Cut to "Sell" at StockNews.com - MarketBeat
Tue, 26 Sep 2023
Analyst Reiterates Buy Rating and Price Target for Glaukos NYSE ... - Best Stocks
Tue, 26 Sep 2023
CNMD vs. ALGN: Which Stock Is the Better Value Option? - Nasdaq
Thu, 21 Sep 2023
CONMED is Now Oversold (CNMD) - Nasdaq
Sun, 17 Sep 2023
CONMED Co. (NYSE:CNMD) Stock Position Lifted by Ameriprise ... - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
31 (M) |
| Shares Float |
30 (M) |
|
% Held by Insiders
|
0.5 (%) |
|
% Held by Institutions
|
120.5 (%) |
|
Shares Short
|
4,020 (K) |
|
Shares Short P.Month
|
3,960 (K) |
Stock Financials |
|
EPS
|
2.99 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
25.38 |
|
Profit Margin (%)
|
7.7 |
|
Operating Margin (%)
|
7.9 |
|
Return on Assets (ttm)
|
2.5 |
|
Return on Equity (ttm)
|
12.1 |
|
Qtrly Rev. Growth
|
14.6 |
|
Gross Profit (p.s.)
|
18.72 |
|
Sales Per Share
|
37.08 |
|
EBITDA (p.s.)
|
5.18 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
37 (M) |
|
Levered Free Cash Flow
|
131 (M) |
Stock Valuations |
|
PE Ratio
|
33.72 |
|
PEG Ratio
|
1.1 |
|
Price to Book value
|
3.97 |
|
Price to Sales
|
2.71 |
|
Price to Cash Flow
|
83.51 |
Stock Dividends |
|
Dividend
|
0.2 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.1% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
